- Home
- SONM vs BIAF Comparison
SONM vs BIAF Comparison
Compare SONM & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SONM
- BIAF
- Stock Information
- Founded
- SONM 1999
- BIAF 2014
- Country
- SONM United States
- BIAF United States
- Employees
- SONM N/A
- BIAF N/A
- Industry
- SONM Telecommunications Equipment
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- SONM Telecommunications
- BIAF Health Care
- Exchange
- SONM Nasdaq
- BIAF Nasdaq
- Market Cap
- SONM 12.6M
- BIAF 12.2M
- IPO Year
- SONM 2019
- BIAF 2022
- Fundamental
- Price
- SONM $0.54
- BIAF $0.23
- Analyst Decision
- SONM
- BIAF Hold
- Analyst Count
- SONM 0
- BIAF 1
- Target Price
- SONM N/A
- BIAF N/A
- AVG Volume (30 Days)
- SONM 409.9K
- BIAF 706.3K
- Earning Date
- SONM 08-08-2025
- BIAF 08-14-2025
- Dividend Yield
- SONM N/A
- BIAF N/A
- EPS Growth
- SONM N/A
- BIAF N/A
- EPS
- SONM N/A
- BIAF N/A
- Revenue
- SONM $57,917,000.00
- BIAF $7,681,059.00
- Revenue This Year
- SONM $127.68
- BIAF N/A
- Revenue Next Year
- SONM N/A
- BIAF $20.00
- P/E Ratio
- SONM N/A
- BIAF N/A
- Revenue Growth
- SONM N/A
- BIAF 4.99
- 52 Week Low
- SONM $0.53
- BIAF $0.16
- 52 Week High
- SONM $6.38
- BIAF $2.26
- Technical
- Relative Strength Index (RSI)
- SONM 35.10
- BIAF 32.85
- Support Level
- SONM $0.54
- BIAF $0.27
- Resistance Level
- SONM $0.60
- BIAF $0.30
- Average True Range (ATR)
- SONM 0.04
- BIAF 0.02
- MACD
- SONM 0.00
- BIAF -0.01
- Stochastic Oscillator
- SONM 4.59
- BIAF 2.58
About SONM Sonim Technologies Inc.
Sonim Technologies Inc is a provider of ultra-rugged mobile devices, including phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The company sells mobile phones, accessories, and solutions to AT&T, T-Mobile, and Verizon in the Canada, and to Bell, Rogers, and Telus and Rogers, Telstra in Australia. The products include rugged mobile phones that can attach to both public and private wireless networks, industrial-grade accessories that meet the requirements of specific applications and software applications, and cloud-based tools that provide management and deployment services to customers. The company generates revenue from discounts, price protection, and customer incentives.
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.